Final close of SPE AIF I
SPE Capital Partners (“SPE Capital”) today announced the final close of SPE AIF I, an Africa-focused private equity fund. SPE AIF I was oversubscribed and closed…
Stéphane Heuzé
SPE Capital is pleased to announce that Stéphane Heuzé has joined the firm as a Managing Partner, to be based out of the Casablanca office.
Saham Pharma
SPE AIF I and Proparco acquire Saham Pharma, a leading antibiotics manufacturer and major hospital provider in Morocco
Dislog Group
SPE AIF I invests in H&S Invest Holding Group, the leading fully integrated FMCG distributor in Morocco
Future Pharmaceutical Industries
SPE AIF I invests in Future Pharmaceutical Industries, a fast-growing Egyptian generic pharmaceuticals manufacturer
Sotipapier
SPE Capital successfully completes a dividend recapitalization, partial exit and capital increase in relation to its investment in Sotipapier
Orchidia Pharmaceutical Industries
SPE Capital successfully exits its investment in Orchidia Pharmaceutical Industries
International School of Carthage
Meninx Holding and SPE Capital successfully acquired the International School of Carthage (ISC)